NOVONESIS (NOVOZYMES) BNOVONESIS (NOVOZYMES) BNOVONESIS (NOVOZYMES) B

NOVONESIS (NOVOZYMES) B

No trades
See on Supercharts

Price target

1,440.490.000.00%
The 17 analysts offering 1 year price forecasts for NSIS/N have a max estimate of — and a min estimate of —.

Analyst rating

Based on 19 analysts giving stock ratings to NSIS/N in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


NSIS/N EPS for the last quarter is 7.85 MXN despite the estimation of 11.27 MXN. In the next quarter EPS is expected to reach 14.10 MXN. Track more of NOVONESIS (NOVOZYMES) B financials and stay on top of what is up with the company.
In the next quarter NOVONESIS (NOVOZYMES) B revenue is expected to reach ‪21.36 B‬ MXN. Check out NOVONESIS (NOVOZYMES) B revenue and earnings and make informed decisions.
According to analysts, NSIS/N price target is 1,440.49 MXN with a max estimate of 1,689.15 MXN and a min estimate of 1,049.23 MXN. Check if this forecast comes true in a year, meanwhile watch NOVONESIS (NOVOZYMES) B stock price chart and keep track of the current situation with NSIS/N news and stock market news.
We've gathered opinions of 19 analysts rating NSIS/N stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.